Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,525 | 29 | 67.0% |
| Food and Beverage | $18,372 | 1,099 | 32.8% |
| Education | $78.41 | 17 | 0.1% |
| Gift | $0.01 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $19,026 | 127 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $12,646 | 58 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $7,620 | 52 | $0 (2022) |
| Allergan, Inc. | $2,890 | 52 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,904 | 133 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $1,529 | 83 | $0 (2024) |
| PFIZER INC. | $903.49 | 65 | $0 (2024) |
| Horizon Therapeutics plc | $860.47 | 54 | $0 (2022) |
| US WorldMeds, LLC | $753.31 | 43 | $0 (2020) |
| Lilly USA, LLC | $700.72 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,373 | 163 | ABBVIE INC. ($4,094) |
| 2023 | $6,664 | 181 | ABBVIE INC. ($4,146) |
| 2022 | $15,071 | 226 | Biohaven Pharmaceutical Holding Company Ltd. ($7,620) |
| 2021 | $21,131 | 253 | Biohaven Pharmaceuticals, Inc. ($12,646) |
| 2020 | $3,122 | 114 | Allergan, Inc. ($1,818) |
| 2019 | $1,231 | 81 | Lilly USA, LLC ($194.19) |
| 2018 | $1,262 | 73 | Amgen Inc. ($184.86) |
| 2017 | $1,122 | 55 | US WorldMeds, LLC ($212.57) |
All Payment Transactions
1,146 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Analgesic | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Central Nervous System | ||||||
| 12/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Analgesic | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Neuromodulation | ||||||
| 12/02/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/02/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Analgesic | ||||||
| 11/14/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Analgesic | ||||||
| 11/07/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: PAIN | ||||||
| 11/02/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Central Nervous System | ||||||
| 10/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Analgesic | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: PAIN | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $15.78 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,124 | 31,190 | $1.8M | $333,251 |
| 2022 | 19 | 1,083 | 24,365 | $1.7M | $336,323 |
| 2021 | 25 | 1,202 | 21,630 | $1.7M | $381,194 |
| 2020 | 28 | 1,329 | 21,636 | $1.9M | $402,345 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 31 | 20,100 | $301,500 | $99,153 | 32.9% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2023 | 35 | 6,675 | $166,875 | $36,015 | 21.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 148 | 619 | $216,650 | $29,511 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 414 | $186,300 | $29,492 | 15.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 56 | 275 | $382,000 | $27,651 | 7.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 32 | 54 | $50,700 | $13,427 | 26.5% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 54 | 55 | $44,000 | $12,628 | 28.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 32 | 54 | $44,500 | $10,841 | 24.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 57 | 58 | $40,600 | $10,050 | 24.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 88 | 184 | $32,200 | $9,953 | 30.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 28 | 28 | $35,280 | $9,166 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 88 | 88 | $35,200 | $8,378 | 23.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 17 | 38 | $30,400 | $6,724 | 22.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 51 | 51 | $51,000 | $6,439 | 12.6% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 31 | 51 | $46,150 | $5,898 | 12.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 31 | 52 | $20,825 | $5,333 | 25.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 17 | 36 | $15,300 | $4,873 | 31.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 35 | 35 | $21,000 | $4,789 | 22.8% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 11 | 11 | $4,950 | $1,542 | 31.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 14 | 23 | $4,370 | $1,181 | 27.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 87 | 2,117 | $21,170 | $205.38 | 1.0% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 18 | 172 | $5,160 | $3.95 | 0.1% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2022 | 40 | 7,150 | $178,750 | $62,205 | 34.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 29 | 12,700 | $190,500 | $61,791 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 429 | $193,050 | $32,209 | 16.7% |
About Dr. Boris Leybel, M.D
Dr. Boris Leybel, M.D is a Pain Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578508685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Boris Leybel, M.D has received a total of $55,976 in payments from pharmaceutical and medical device companies, with $6,373 received in 2024. These payments were reported across 1,146 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,525).
As a Medicare-enrolled provider, Leybel has provided services to 4,738 Medicare beneficiaries, totaling 98,821 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location New York, NY
- Active Since 06/20/2006
- Last Updated 04/23/2015
- Taxonomy Code 2084P2900X
- Entity Type Individual
- NPI Number 1578508685
Products in Payments
- NURTEC ODT (Drug) $20,910
- UBRELVY (Drug) $14,182
- QULIPTA (Drug) $7,016
- ZTLido (Drug) $1,460
- PENNSAID (Drug) $747.68
- AJOVY (Biological) $725.07
- EMGALITY (Drug) $600.45
- AUSTEDO (Drug) $549.94
- Austedo XR (Drug) $540.14
- BOTOX (Biological) $539.27
- Apokyn (Drug) $469.82
- INGREZZA (Drug) $432.18
- Aimovig (Biological) $368.71
- Xadago (Drug) $344.29
- XTAMPZA (Drug) $340.87
- ORTHOVISC (Device) $328.14
- NUPLAZID (Drug) $306.20
- TRINTELLIX (Drug) $255.19
- MYOBLOC (Biological) $252.98
- Nourianz (Drug) $250.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in New York
Amitabh Gulati, Md, MD
Pain Medicine — Payments: $593,303
Dr. David Spinner, D.o, D.O
Pain Medicine — Payments: $371,830
Dr. Eric Lee
Pain Medicine — Payments: $269,035
Dr. Chirag Shah, M.d., J.d, M.D., J.D
Pain Medicine — Payments: $44,312
Annie Layno-Moses
Pain Medicine — Payments: $30,828
Dr. Scott Maddalo, M.d, M.D
Pain Medicine — Payments: $21,573